Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
INTERVENTIONAL
2011-12-31
2013-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Growth of Infants Fed a New Term Infant Formula
NCT03090360
The Effects on Growth of a Non-Routine Infant Formula
NCT00655720
Growth of Infants Fed New Starter Formula
NCT01079208
Single Vs Multi-strain Probiotics for Preterm Neonates
NCT07296718
Safety and Efficacy of Infant Formulas Supplemented With Pre- and Probiotic(s)
NCT04962594
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control infant formula
partially hydrolyzed whey infant formula
Control infant formula
partially hydrolyzed whey infant formula consumed ad libitum throughout study
test infant formula
partially hydrolyzed whey infant formula with probiotic
Test infant formula
partially hydrolyzed whey formula with probiotic
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Control infant formula
partially hydrolyzed whey infant formula consumed ad libitum throughout study
Test infant formula
partially hydrolyzed whey formula with probiotic
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Full-term
* Birth weight \> 2500 and \< 4500 g
* 14±3 days of age on enrollment
* Exclusively formula-fed, singleton birth
* Having obtained his/her legal representative's informed consent
Exclusion Criteria
* Congenital illness or malformation that may affect infant feeding and/or growth
* Significant prenatal and/or postnatal disease
* Any readmission to hospital prior to enrollment
* Receiving prescription medication or frequent use of over the counter medications except vitamin and mineral supplements
* Has received intravenous antibiotic therapy or oral probiotic in the last 7 days
* Currently participating in another clinical study
* Cannot be expected to comply with treatment
11 Days
17 Days
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Société des Produits Nestlé (SPN)
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
North Scottsdale Pediatric Associates
Scottsdale, Arizona, United States
Pediatrics & Adolescent Medicine
Marietta, Georgia, United States
Kentucky Pediatric Adult Research
Bardstown, Kentucky, United States
PMG Research of Winston-Salem
Winston-Salem, North Carolina, United States
Medical University of South Carolina
Charleston, South Carolina, United States
PMG Research of Bristol
Bristol, Tennessee, United States
Pediatric Healthcare of Northwest Houston
Tomball, Texas, United States
Advanced Pediatrics
Vienna, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10.01.US.INF
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.